| アブストラクト | The use of new oral anticoagulants such as apixaban is increasing. We present the case of an 85-year-old patient who was diagnosed with mixed profile toxic hepatitis due to apixaban use. An etiological study was negative, except for anti-smooth muscle antibodies, and a liver biopsy ruled out autoimmune hepatitis. The patient was assigned a score of 7 on the CIOMS/RUCAM scale, indicating a probable causality. The liver injury improved after the withdrawal of apixaban. A previous meta-analysis reported that the risk of hepatotoxicity does not increase with the use of apixaban, nor were any cases reported in registry studies. Nonetheless, more than 120 possible cases currently appear in the European pharmacovigilance database (EudraVigilance). We suggest that apixaban should be considered as a possible cause of liver injury. |
|---|
| ジャーナル名 | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva |
|---|
| Pubmed追加日 | 2018/12/21 |
|---|
| 投稿者 | Machlab, Salvador; Miquel, Mireia; Vergara, Mercedes; Escoda, Maria Rosa; Casas, Meritxell |
|---|
| 組織名 | Servicio de Aparato Digestivo, Corporacio Sanitaria Universitaria Parc Tauli.;Universitat Autonoma de Barcelona, Espana.;Universitat Autonoma de Barcelona.;Servicio de Anatomia Patologica, Corporacio Sanitaria Universitaria Parc Tauli.;Universitat Autonoma de Barcelona. . |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/30569731/ |
|---|
